New Product Development
Additionally, the market is advancing as novel, rapid, and precise testing tools. The Americas COVID-19 testing market was valued at around USD 5.8 Billion in 2025, backed by the continued need for diagnostic products and services amid persistent monitoring and surveillance initiatives. The global market is estimated to be over USD 10.5 Billion by 2035 …
Continue reading “Americas COVID-19 Testing Market Set to Grow at 6.2% CAGR Through 2035”
The COVID-19 testing market in the Americas is projected to experience steady growth over the next decade, according to recent data. Valued at USD 5.1 billion in 2023, the market is forecasted to expand at a CAGR of 6.7%, reaching an impressive valuation of USD 9.8 billion by 2033. This trajectory underscores the ongoing importance …
The Americas COVID-19 testing market is currently valued at approximately USD 5.1 billion in 2023 and is expected to grow significantly, reaching an estimated USD 9.8 billion by 2033. This represents a robust compound annual growth rate (CAGR) of 6.7% throughout the forecast period. As the world continues to navigate the impacts of the COVID-19 …
The battle against COVID-19 has ignited a surge in the America’s COVID-19 Testing Market. According to a recent analysis, the market, valued at USD 5.1 billion in 2022, is projected to reach a significant USD 9.8 billion by 2033. This impressive growth translates to a Compound Annual Growth Rate (CAGR) of 6.7% during this period. …
The COVID-19 pandemic fundamentally altered the healthcare landscape, with testing playing a crucial role in managing the outbreak. This trend is expected to persist, according to a recent analysis by Future Market Insights (FMI), a leading market research firm. The analysis projects the American COVID-19 Testing Industry to reach a staggering US$9.8 billion by 2033. …
America’s COVID-19 Testing Industry has experienced significant growth in recent years, according to a recent market analysis by Future Market Insights (FMI). The market, valued at an impressive US$5.1 billion in 2022, is expected to continue its upward trajectory, reaching an estimated US$9.8 billion by 2033. This growth is projected to be fueled by a …
The Americas’ COVID-19 Testing Industry has witnessed an unprecedented surge, reaching an impressive valuation of US$ 5.1 billion in 2022. The future looks even more promising, with forecasts projecting a staggering market value of US$ 9.8 billion by 2033, fueled by an outstanding Compound Annual Growth Rate (CAGR) of 6.7%. The ongoing COVID-19 pandemic has …
In a groundbreaking revelation, the Americas COVID-19 Testing Industry is currently valued at an impressive US$ 5.1 billion in 2023, with projections indicating a remarkable surge to US$ 9.8 billion by the year 2033. This surge reflects a robust Compound Annual Growth Rate (CAGR) of 6.7% over the forecast period. The growing number of COVID-19-infected …
The Global Americas’ COVID-19 Testing Industry has surged to an impressive valuation of US$ 5.1 billion in 2022, and the forecast is even more promising. By 2033, the market is projected to reach an astounding US$ 9.8 billion, driven by a remarkable Compound Annual Growth Rate (CAGR) of 6.7%. The global healthcare landscape has been …
